• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Journal of Biological Sciences
  2. Vol 3 (6), 2003
  3. 561-577
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Journal of Biological Sciences

Year: 2003 | Volume: 3 | Issue: 6 | Page No.: 561-577
DOI: 10.3923/jbs.2003.561.577
crossmark

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
Research Article

Light and Electron Microscopic Studies of the Effect of Tamoxifen on the Testes of Male Mice

Azza A. Attia

ABSTRACT


The effect of oral administration of tamoxifen (a synthetic non-steroidal antiestrogen) at doses of 20 and 40 mg/kg/day for 60 days on the potency, the fecundity, the circulating concentrations of both Luteinizing hormone (LH) and testosterone and the ultrastructural changes of the male testicular tissues of mice were determined. Forty mg/kg/day tamoxifen was more effective than 20 mg/kg/day in reducing the male mice`s ability to inseminate the female (potency), as well as its siring ability (fecundity). Both doses of tamoxifen had reduced the concentrations of testosterone in plasma while circulating LH levels were significantly increased in the blood of mice taken 40 mg/kg/day tamoxifen comparing to those taken 20 mg/kg/day and the control. Light microscopic results showed that sections of mice testes treated with tamoxifen revealed the presence of severely damaged and entirely normal seminiferous tubules adjacent to one another in the same section. However, most sections of mice testes showed disorganization of cytoarchitecture arrangement of seminiferous tubules with obliterated lumen. This was accompanied by an obvious occurrence of vacuolated tubules in most sections of these testes. 40 mg/kg/day tamoxifen had devoid the mature sperm in most tubules and the reduction in Leydig interstitial cells was parallel to the decrease in testosterone levels. At the electron microscopic level, wide intercellular vacuolation between the spermatogenic cells and large numerous cytoplasmic vacuoles in most spermatids were seen. Clear sign of karyolysis and karyorrhexis in degenerating spermatocytes were observed. The Sertoli cells in a number of sections had an increased electron density with marked dilated smooth endoplasmic reticulum and numerous dense bodies were dispersed throughout the cytoplasm. Thus, the study supports that the tamoxifen as a potent antiestrogen, has a direct effect in inhibiting the testosterone synthesis and hence altered spermatogenesis and testicular morphology at low and high doses. Thus, it can be used as a potential contraceptive agent.
PDF References Citation

How to cite this article

Azza A. Attia, 2003. Light and Electron Microscopic Studies of the Effect of Tamoxifen on the Testes of Male Mice. Journal of Biological Sciences, 3: 561-577.

DOI: 10.3923/jbs.2003.561.577

URL: https://scialert.net/abstract/?doi=jbs.2003.561.577

REFERENCES


  1. Allard, E.K., K.I. Johnson and K. Bochetheirde, 1993. Colchicines disrupts the cytoskeleton of rat testis seminiferous epithelium in a stage B dependent manner. Bio. Reprod., 48: 143-153.

  2. Bartke, A., K.L.H. Williams and S. Dalterio, 1977. Effects of estrogen on testicular testosterone production in vitro. Biol. Reprod., 17: 645-649.

  3. Burkitt, H. G., B. Young and J. W. Health, 1999. Wheater's Functional Histology. 3rd Edn., Churchill Livingstone, London.

  4. Buvat, J., A. Gautheir, K. Ardaens, M. Buvat-Herbaut and A. Lemaire, 1982. Effects du tamoxifen sur les hormones et le sperme de 80 sujets oligospermiques et asthenospermiques. J. Gynecol. Obstet. Biol. Reprod., 11: 407-412.

  5. Comhaire, F., 1976. Treatment of oligospermia with tamoxifen. Int. J. Fertil., 21: 232-237.

  6. Creasy, D.M. and P.M.D. Foster, 1991. Male Reproductive System. In: Handbook of Toxicologic Pathology, Haschek, W.M. and C.G. Rousseaux (Eds.). Academic Press, London and New York, pp: 829-874

  7. Dyn, M. and D. Fawcett, 1970. The blood-testis barrier in the rat and the physiological compartmentation of the seminiferous epithelium. J. Biol. Reprod., 3: 308-316.

  8. Flickinger, C.J. and C.K. Loving, 1976. Fine structure of the testis and epididymis of rats treated with cyproterone acetate. Am. J. Anat., 146: 359-384.

  9. Furr, B.J.A. and V.C. Jordan, 1984. The pharmacologiy and clinical uses of tamoxifen. Pharmacol. Therapeutics, 25: 127-205.

  10. Gartner, I.P. and J.L. Hiatt, 1997. Histology. W.B. Saunders Company, USA.

  11. Gill-Sharma, M.K., K. Gopalkrishnan, N. Balasinor and P. Parte, 1993. Effects of tamoxifen on the fertility of male rats. J. Reprod. Fertility, 99: 395-402.

  12. Harper, M.J.K. and A. L. Walpole, 1966. Contrasting endocrine activities of cis-and trans-isomers in a series of substituted triphenylethylene. Nature, 212: 87-94.

  13. Haschek, W.M. and C.G. Rousseaux, 1991. Handbook of Toxicologic Pathology. Academic Press, London and New York.

  14. Jordan, V.C. and S. Koerner, 1975. Tamoxifen (ICI46,474) and the human carcinoma 8S oestrogen receptor. Eur. J. Cancer, 11: 205-206.

  15. Jordan, V.C. and C.S. Murphy, 1990. Endocrine pharmacology of antiestrogens as antitumor agents. Endocrine Res., 11: 578-610.

  16. Junqueira, L.C., J. Cameiro and R.O. Kelley, 1998. Basic Histology. 9th Edn., Appleton and Langue, USA.

  17. Kliesch, G., P.T.K. Penttila, E. Saunder, A. Nieschlag and M. Parvinen, 1992. FSH receptor mRNA is expressed stage-dependently during spermatogenesis. Mol. Cell Endocrinolo., 84: 45-49.

  18. Lin, T., E.P. Muronon, J. Osterman and H.R. Nankin, 1981. Glycolytic and oxidative metabolism in relation to retinal function. Metabolism, 30: 150-159.

  19. McEwen, B.S., 1975. Hormones, receptors and brain function. Adv. Pathol., 1: 56-59.

  20. Muldoon, T.H.G., 1977. Pituitary Estrogen Receptors. In: Pituitary Estroggen Receptors, Allen, M.B. and V.B. Mahesh (Eds.). Academic Press, New York, pp: 295-326

  21. Nakai, M., K. Uchida, C. Teuscher, 1999. Development of male reproductive organ abnormalities after neonatal expoure to tamoxifin is genetically determined. J. Androl., 20: 626-634.
    Direct Link

  22. Orgebin-Crist, M.C., B.J. Danzo and J. Davies, 1975. Endocrine Control of the Development and Maintenance of Sperm Fertilizing Ability in the Epididymis. In: Handbook of Physiology, Greep, R.O. and E.B. Astwood (Eds.). Vol. 5, American Physiological Society, Washington, DC., pp: 319-338

  23. Laurence, D.R. and A.L. Bacharach, 1964. Evaluation of Drug Activities Pharmacometrics. Academic Press, Cambridge, Massachusetts, ISBN: 978-1-4832-2845-7, Pages: 456.
    CrossRefDirect Link

  24. Passing, H. and W. Bablok, 1984. Comparison of several regression procedures for method comparison studies and determination of sample sizes. J. Clin. Chem. Clin. Biochem., 22: 431-445.

  25. Russell, L., J. Malone, S. Karpas, 1981. Morphological pattern elicited by agents affecting spermatogenesis by disruption of its hormonal stimulation. Tissue Cell, 13: 296-380.

  26. SAS, 1986. User's Guide Statistics. SAS Institute, NC. USA.

  27. Sharpe, R.H., M. Millar and C. McKinnel, 1993. Relative roles of testosterone and germ cell complement in determining stage-dependent changes in protein secretion by isolated rat seminiferous tubule. Int. J. Androl., 16: 71-81.

  28. Steinberger, E.C., 1971. Hormonal control of mammalian spermatogenesis. Physiol. Rev., 51: 1-22.
    PubMed

  29. Vermeulen, A. and F. Comhaire, 1978. Hormonal effects of an antiestrogen tamoxifen in normal and oligospermic men. Fertil. Sreril., 29: 320-327.

  30. Yanaihara, T. and P. Troen, 1974. Studies of human testis: III Effect of estrogen on testosterone formation in human testis in vitro. J. Clin. Endocrinol. Metab., 34: 968-973.

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved